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Research
Antibiotic pollution may facilitate the 
develop ment and spread of anti biotic resis­
tance (Martinez 2008). Antibiotics used in 
human and veterinary medicine can enter the 
environ ment via waste water treatment plant 
effluents, hospital and processing plant efflu­
ents, application of agricultural waste and bio­
solids to fields, and leakage from waste­storage 
containers and landfills (Kümmerer 2009a; 
Sarmah et al. 2006). One of the difficulties 
of relating increased levels of resistance in the 
environment to anti biotic pollution, however, 
is the fact that anti biotic resistance genes can 
be co­released into the environment with anti­
biotic compounds (Kümmerer 2009b). The 
question then is whether an observed increase 
in resistance emerged as a result of the selective 
pressure of the anti biotic in the environment 
or if it emerged within the treated host.
Antibiotic resistance genes and anti biotic 
compounds are different pollutants that 
have different modes of action and are sub­
ject to different fate processes in the environ­
ment (Martinez 2009). They are also likely 
to respond differently to treatment processes 
designed to remove them from environ mental 
compartments and from liquid and solid wastes 
(Pei et al. 2007). Estimating the rela tive contri­
bution of pollution by anti biotic resistance 
genes and anti biotic compounds to increased 
levels of anti biotic resistance is important, as 
this knowledge may be used to improve the 
effectiveness of counter active measures. 
Except for the the report by Kristiansson 
et al. (2011), who found excessive concentra­
tions of anti biotics and concurrent high lev­
els of resistance in streams receiving effluents 
from a drug­production plant in India, there is 
limited evidence as to whether environ mental 
concentra tions of anti biotics can enhance 
the develop ment and spread of resistance in 
the environ ment (e.g., Knapp et al. 2008). 
Current guidelines on the environ mental risk 
assessment of medicinal products for human 
and veterinary use in the European Union, for 
example, do not explicitly address the effect 
of anti biotics on the prevalence of anti biotic 
resistance in the environ ment [European 
Medicines Agency (EMEA) 2006, 2008].
From an environ mental health perspective, 
the selective pressure that anti biotic pollution 
may exert on clinically important bacteria is 
of particular concern. Several clinically rele­
vant bacteria, such as Escherichia coli and the 
enterococci, occur and are able to grow in 
different environ ments (Moriarty et al. 2008; 
Topp et al. 2003). In the presence of environ­
mental concentrations of anti biotics, they may 
face a selective pressure leading to a gradual 
increase in the prevalence of resistance.
In the present study we used bacterial spe­
cies sensitivity distributions derived from a 
comprehensive set of minimum inhibi tory con­
centration (MIC) distributions of anti biotics 
to model bacterial sensitivities and characterize 
the selective pressure that anti biotic pollution 
may exert on bacteria of importance to public 
health that are found in the environ ment. The 
study was carried out under the premise that 
anti biotics will primarily increase the preva­
lence of resistance by favoring the selection of 
resistant pheno types via the inhibition of sensi­
tive ones. Although there is evidence to suggest 
that sub inhibitory concentrations of anti biotics 
may indirectly favor resistance (Hoffman et al. 
2005), the use of bacterial inhibition as an 
assessment end point provides a standardized 
response across taxa that can be directly linked 
to a selective pressure favoring an increase in 
the prevalence of resistance.
We derived species sensitivity distribu­
tions for three anti biotics from publicly avail­
able MIC distributions and determined the 
fraction of inhibited bacterial taxa at anti­
biotic concentrations that were measured in 
different environ ments and used as action 
limits in environ mental risk assessment. To 
our knowledge, this is the first study in which 
measured environ mental concentrations of 
anti biotics are examined in regard to the anti­
biotic sensitivity of clinically rele vant bacteria. 
Methods
MIC distributions. We obtained MIC distri­
butions for cipro floxacin, erythro mycin, and 
tetra cycline from the European Committee 
on Antimicrobial Susceptibility Testing 
(EUCAST) MIC and zone diameter distri­
bution website (EUCAST 2010; Kahlmeter 
et al. 2003). Distributions are based on data 
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collated from > 20,000 different worldwide 
sources and encompass the variability within 
species and between researchers, methods, 
and geographic areas.
Ciprofloxacin, erythro mycin, and tetra­
cycline were selected from among a list of 
approximately 150 compounds in the data­
base for three reasons: a) they represent three 
distinct classes of anti biotics of importance to 
human and veterinary medicine; b) the num­
ber of bacterial taxa represented in their MIC 
distributions was higher than in most of the 
other compounds in the database; and c) they 
have been measured in different environ­
mental compartments.
Phylogenetic analysis. To place bacteria 
represented in the EUCAST MIC distributions 
in a wider phylogenetic context, we conducted 
a brief phylo genetic analysis. 16S rRNA 
sequences from bacterial taxa represented in 
the MIC distributions were obtained from the 
All­Species Living Tree Project (LTP; Yarza 
et al. 2008), March 2011 release, and imported 
into ARB software (Ludwig et al. 2004). We 
selected bacterial taxa represented in the MIC 
distributions of cipro floxacin, erythro mycin, 
and tetra cycline to create a pooled 16S rRNA 
sequence alignment comprising the species 
represented in the MIC distributions of all 
three anti biotics. Some bacterial taxa were not 
represented in the LTP database; therefore, 
the alignment contained a subset of the taxa 
represented in each original MIC distribution 
[see Supplemental Material, Table S1 
(http://dx.doi.org/10.1289/ehp.1104650)]. 
This alignment, along with the entire LTP 
alignment for the domain Bacteria, was 
imported into the ape package (version 2.6­2) 
of the R environment for statistical computing 
(Paradis and Strimmer 2004); we then 
calculated an evolutionary distance matrix 
for each alignment using Kimura’s two­
parameter substitution model (Kimura 1980). 
An unrooted phylo genetic dendrogram was 
estimated from the evolutionary distance 
matrix of the pooled anti biotic alignment 
using the neighbor­joining method (Saitou 
and Nei 1987), and confidence was assessed by 
boot strapping with 1,000 permutations. We 
plotted histograms of pairwise evolutionary 
distances covered by the pooled 16S rRNA 
alignment of species represented in the MIC 
distributions of all three anti biotics and by the 
entire LTP alignment for the domain Bacteria 
to assess the range of evolutionary distances 
covered by our data set in relation to that of all 
sequenced type strains of bacteria.
Bacterial species sensitivity distributions. 
End point selection. Species sensitivity dis­
tributions were derived using the median 
MIC (MIC50) and the no observed effect 
MIC (NOEC) of each taxon. MIC tests are 
performed using double­dilution steps of 
anti biotic concentrations, and the data they 
generate is interval censored. Therefore, we 
considered the conservative MIC50 of each 
species to be the anti biotic concentration 
immediately below the observed 50th percen­
tile, and the NOEC to be the anti biotic con­
centration immediately below the lowest MIC 
observed in each taxon. MIC50 and NOEC 
values were aggregated within cogeneric spe­
cies by using the arithmetic mean to minimize 
the lack of independence between individ­
ual observations [see Supplemental Material, 
Section 1 and Figure S1 (http://dx.doi.
org/10.1289/ehp.1104650)]. To derive spe­
cies sensitivity distributions, we used pooled 
MIC50 and NOEC values only from genera 
for which there was evidence to suggest that—
under certain conditions—the genera could 
grow in an environ mental compartment (e.g., 
soil, sewage, fresh water) (for details regard­
ing the selection of genera, see Supplemental 
Material, Section 2 and Table S2). 
Linking end points to resistance. The 
MIC50 was calculated including data beyond 
the wild­type cut­off value (COWT). The 
COWT separates micro organisms with (i.e., 
non–wild­type) and without (i.e., wild­type) 
acquired resistance mechanisms and represents 
an anti biotic concentration above which only 
bacteria with acquired resistance mechanisms 
can grow (Kahlmeter et al. 2003) A compari­
son of MIC50 values with the wild­type MIC 
range of species in the EUCAST distribu­
tions indicates that the MIC50 is an adequate 
estimate of the wild­type MIC (i.e., it falls 
within the wild­type MIC range in those spe­
cies that have one), except for a few cases in 
which it falls above the wild­type MIC range. 
Concentrations of anti biotics ≥ MIC50 are 
therefore likely to inhibit approximately half 
of the wild­type population. Assuming equal 
growth rates of wild­type and resistant popula­
tions, this causes an increase in the prevalence 
of resistance in the remaining active popula­
tions (Figure 1). In contrast, the NOEC rep­
resents a minority of isolates across taxa whose 
MIC values are sometimes below the MIC 
range representative of the wild­type popula­
tion; we used the NOEC as a means to assess 
the lower limit of anti biotic sensitivity repre­
sented in the MIC distributions. 
Bootstrap regression. We derived species 
sensitivity distributions by bootstrap regres­
sion, as described by Grist et al. (2002). The 
MIC50 and NOEC vectors of each anti biotic 
were resampled 5,000 times. To each of these 
boot strap resamples, a log­logistic model was 
fitted by maximum likeli hood estimation of 
the distribution parameters and direct optimi­
zation of the log­likelihood function following 
the method of Nelder and Mead (1965) and 
using the fitdistrplus package, version 0.1–4, 
of the R environment for statistical computing 
(Delignette­Muller et al. 2010). The distribu­
tion parameters α (i.e., location) and β (i.e., 
scale) from each fitted curve were used to 
derive 5,000 replicate estimates of anti biotic 
concentrations associated with a potentially 
affected fraction between percentiles 0.01 and 
0.99 at 0.01­step intervals. From these, the 
bootstrap estimate and 95% bootstrap con­
fidence intervals (CIs) were calculated. The 
MIC distributions used in this study, along 
with an R script to replicate the analysis, are 
available from the authors.
We determined the potentially affected 
fraction of bacterial genera by all three anti­
biotics at the aquatic and soil VICH phase I 
action limits [International Cooperation on 
Harmonisation of Technical Requirements for 
Registration of Veterinary Medicinal Products 
(VICH) 2000] and at measured environ mental 
concentrations reported in the literature (e.g., 
Kolpin et al. 2002). This was complemented 
with a direct compari son of measured environ­
mental concentrations and VICH action 
limits with the COWT of species represented 
in the MIC distributions of each anti biotic. 
Although cipro floxacin is not approved for use 
in veterinary medicine, it is the major active 
metabolite of enro floxacin in different spe­
cies (Idowu et al. 2010). In the absence of 
data for enro floxacin, we used cipro floxacin 
as a representative of the fluoro quinolones in 
Figure 1. Conceptual link between the MIC50 and 
anti biotic concentrations > COWT with resistance 
prevalence in a universe (Ω) including resistant 
(black) and wild-type (gray) populations, and its 
relation to the MIC distribution. Antibiotic concen-
trations > COWT completely inhibit wild-types, and 
resistance prevalence in the active (i.e., grow-
ing) population will be 100%. Concentrations of 
antibiotics ≤ COWT, such as the MIC50, will inhibit 
a fraction of the wild-type population (e.g., 50%). 
If we assume equal growth rates of wild-type and 
resistant popu lations, the prevalence of anti biotic 
resistance will increase in the active population. 
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comparisons of potentially affected fractions 
and VICH phase I action limits. We obtained 
measured environ mental concentrations of 
cipro floxacin, erythro mycin, and tetra cycline 
from Kolpin et al. (2002), Golet et al. (2002), 
and Luo et al. (2011), and from data collated 
by Hamscher (2006). Antibiotic concentra­
tions are expressed as parts per billion to facili­
tate analysis and compari sons.
Results
Phylogenetic and environ mental overview of 
MIC distributions. Seventy­nine species from 
the cipro floxacin, erythro mycin, and tetra­
cycline MIC distributions were represented 
in the LTP 16S rRNA database [Figure 2; see 
also Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1104650)]. Major 
bacterial groups in Figure 2 (appearing in 
order from top to bottom in the dendro gram) 
include staphylo cocci, entero cocci, strepto cocci, 
a few representatives of the Actinobacteria 
(e.g., Clostridium spp., Mycobacterium spp.), 
Bacteroides, pseudomonads (e.g., Pseudomonas 
spp., Burkholderia spp.), and the enterics (e.g., 
Escherichia spp., Enterobacter spp., Proteus spp., 
Klebsiella spp.). The range of evolutionary dis­
tances covered by these species spans the range 
of evolutionary distances represented in the 
entire LTP database, high lighting it as a rather 
diverse phylo genetic group (Figure 3).
Bacterial genera used to derive the spe­
cies sensitivity distribution of each anti biotic 
Table 1. Bacterial genera included in the species 
sensitivity distribution of each anti biotic. 
Genus Cipro Eryth Tetra
1 Acinetobacter + – +
2 Alcaligenes + – –
3 Burkholderia + – –
4 Campylobacter + + +
5 Chryseobacterium + – –
6 Citrobacter + – +
7 Clostridium – + +
8 Enterobacter + – +
9 Enterococcus + + +
10 Escherichia + – +
11 Hafnia + – +
12 Klebsiella + – +
13 Kluyvera + – +
14 Legionella + + –
15 Listeria + – +
16 Morganella + – +
17 Pasteurella + + +
18 Proteus + – +
19 Providencia + – –
20 Pseudomonas + – +
21 Raoultella + – +
22 Salmonella + – +
23 Serratia + – +
24 Staphylococcus + + +
25 Stenotrophomonas + – +
26 Streptococcus + + +
27 Yersinia + – +
Abbreviations: Cipro, cipro floxacin; Eryth, erythro mycin; 
Tetra, tetra cycline. “+” and “–” symbols indicate presence 
or absence, respectively, of the genera in each data set. 
Figure 2. Unrooted neighbor-joining dendrogram of species (by LTP name) represented in the pooled 16S 
rRNA alignment of cipro floxacin, erythro mycin, and tetracycline. Species highlighted in red were not 
included in the species sensitivity distributions due to lack of evidence of growth in the environment. Bar 
units indicate the number of nucleotide substitutions per site. Black nodes indicate ≥ 70% bootstrap support; 
blue nodes indicate < 70% bootstrap support. Full species names are available in Supplemental Material, 
Table S1 (http://dx.doi.org/10.1289/ehp.1104650). 
Figure 3. Histograms showing the range of pairwise evolutionary distances covered by (A) the pooled 
16S rRNA alignment of species represented in the MIC distributions of all three antibiotics, and (B) the 
entire LTP 16S rRNA alignment for the domain Bacteria. Pairwise evolutionary distances in A were calcu-
lated from the same 16S rRNA alignment used to construct the dendrogram in Figure 2. 
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represent commensal and pathogenic bacte­
ria that occur, and may grow, to a larger or 
lesser extent in the environ ment (Table 1). 
Among the 27 genera included in the species 
sensitivity distributions are some known to be 
widely distributed in the environ ment, such 
as Pseudomonas, Acinetobacter, Burkholderia, 
and Chryseobacterium (Madigan et al. 2009; 
Vandamme et al. 1994), as well as others for 
which growth in the environ ment has either 
been reported or for which there is evidence to 
suggest that under certain conditions it is likely 
to occur [see Supplemental Material, Table S2 
(http://dx.doi.org/10.1289/ehp.1104650)].
Inhibitory effects at environ mental con-
centrations. The log­logistic model had a good 
fit to the NOEC and MIC50 vectors, explain­
ing ≥ 90% of the variance in the original data 
(Figure 4). Table 2 shows that the potentially 
affected fraction of bacterial genera at mea­
sured environ mental concentrations of cipro­
floxacin, erythro mycin, and tetra cycline in 
water environ ments—including surface water, 
sewage treatment plant (STP) effluents, raw 
sewage, and ground water—is low, with upper 
95% CIs of 7% and 3.2% in raw sewage for 
cipro floxacin using the NOEC and MIC50 
species sensitivity distributions, respectively. At 
the low range of concentrations measured in 
surface waters and STP effluents, the practical 
difference between potentially affected fraction 
estimates is minimal using the NOEC and 
MIC50 species sensitivity distributions. For 
erythro mycin, the NOEC and MIC50 species 
sensitivity distributions overlap at the lower 
tail of the distributions, causing the MIC50 
species sensitivity distribution to estimate 
slightly higher potentially affected fractions 
than the NOEC species sensitivity distribution 
for concentrations measured in surface waters 
Figure 4. Species sensitivity distributions derived for the NOEC (black) and MIC50 (red) curves with overlayed empirical cumulative distributions (dots). Fitted 
curves represent the bootstrap estimate and 95% bootstrap CIs for the log-logistic model. Dashed and solid blue vertical lines represent the VICH phase I aquatic 
and soil action limits, respectively. (A) Ciprofloxacin: NOEC (R 2 = 0.90; p < 0.0001), MIC50 (R 2 = 0.91; p < 0.0001); bootstrap estimate of model parameters: NOEC 
species sensitivity distribution (α = –2.1, β = 0.37), MIC50 species sensitivity distribution (α = –1.0, β = 0.54). (B) Erythromycin: NOEC (R 2 = 0.96; p < 0.001), MIC50 
(R 2 = 0.97; p < 0.0001); bootstrap estimate of model parameters: NOEC species sensitivity distribution (α = –1.13, β = 0.29), MIC50 species sensitivity distribution 
(α = –0.014, β = 0.48). (C) Tetracycline: NOEC (R 2 = 0.97; p < 0.0001), MIC50 (R 2 = 0.98; p < 0.0001); bootstrap estimate of model parameters: NOEC species sensitivity 
distribution (α = –0.84, β = 0.27), MIC50 species sensitivity distribution (α = 0.2, β = 0.33). The potentially affected fraction of bacterial genera at a given anti biotic 
concentration is read from the y-axis at the point in which the anti biotic concentration intersects with the species sensitivity distribution. For example, a con-
centration of 100 ppb (i.e., log10 concentration = 2) of cipro floxacin inhibits approximately one-half of the wild-type population (i.e., red MIC50 curve) in 54% of the 
bacterial genera and at least some individuals (i.e., black NOEC curve) in 95% of the bacterial genera. 
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Table 2. Potentially affected fraction for each anti biotic at measured environmental concentrations and 
environmental risk assessment action limits using the NOEC and MIC50 species sensitivity distributions.
Potentially affected fraction (95% CI)
Antibiotic/environment Concentration (ppb)
NOEC species 
sensitivity distribution
MIC50 species 
sensitivity distribution
Ciprofloxacin
Surface water 0.03a 0.1 (0.008, 0.4) 0.2 (0.03, 0.4)
0.36b 2.3 (0.7, 4.3) 1.2 (0.4, 2.3)
River sediments 48b 89 (75, 99) 40 (23, 60)
STP effluent 0.37b 2.4 (0.7, 4.4) 1.2 (0.4, 2.3)
0.062c 0.3 (0.03, 0.8) 0.3 (0.1, 0.7)
0.11c 0.6 (0.08, 1.3) 0.4 (0.1, 1)
Raw sewage 0.313c 2 (0.5, 3.8) 1.1 (0.4, 2)
0.568c 4 (1.6, 7) 1.7 (0.6, 3.2)
Swine feces lagoon sediment 340b 99 (95, 100) 76 (59, 92)
VICH phase I limit (aquatic) 1 8 (4, 12) 2.7 (1, 4.7)
VICH phase I limit (terrestrial) 100 95 (86, 100) 54 (36, 76)
Erythromycin
Surface water 0.024b 0.0001 (0, 0.02) 0.003 (0, 0.09)
River sediments 19b 8.6 (0.5, 23) 2 (0.03, 7.6)
STP effluent 0.07b 0.0008 (0, 0.07) 0.008 (0, 0.2)
Swine feces lagoon sediment 80b 53 (21, 92) 7.9 (0.4, 21)
VICH phase I limit (aquatic) 1 0.07 (0, 1) 0.1 (0, 1)
VICH phase I limit (terrestrial) 100 62 (27, 97) 9.7 (0.5, 25)
Tetracycline
Surface water 0.11a 0.0006 (0, 0.03) 0.0003 (0, 0.01)
0.42b 0.006 (0, 0.2) 0.002 (0, 0.04)
River sediments 73b 24 (8, 44) 1.6 (0.3, 6)
STP effluent 0.16d 0.001 (0, 0.05) 0.0005 (0, 0.02)
0.98d 0.02 (0, 0.4) 0.005 (0, 0.09)
0.09b 0.0004 (0, 0.02) 0.0002 (0, 0.009)
Swine feces lagoon sediment 1,100b 97 (92, 99) 38 (22, 56)
Liquid manure 66,000d 100 (100, 100) 99 (97, 100)
Farmed soil 443d 86 (77, 94) 15 (6.6, 30)
Groundwater 0.13d 0.0008 (0, 0.04) 0.0004 (0, 0.01)
VICH phase I limit (aquatic) 1 0.02 (0, 0.4) 0.005 (0, 0.09)
VICH phase I limit (terrestrial) 100 35 (14, 55) 2.4 (0.5, 8.1)
aOccurrence data (maximum measured concentrations) from Kolpin et al. (2002). bOccurrence data from supporting 
information, Table S6, of Luo et al. (2011). Concentrations greater than the limit of detection were averaged over sam-
pling stations for sites “Tributaries Water, Dec 2009,” “Tributaries Sediment Dec 2009,” “Pollution source water Dec 
2009” for S1 and S2, and “Source Sediments Dec 2009” for S3 and S4; surface water concentrations and river sediment 
concentrations are from corresponding sampling sites. cOccurrence data (mean measured concentrations) from Golet 
et al. (2002). dOccurrence data (maximum measured concentrations) collated by Hamscher (2006). 
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and STP effluents. Given that the potentially 
affected fractions of both species sensitivity 
distributions are well below 1% at this range 
of concentrations, this discrepancy was not 
significant for our assessment of effects.
Potentially affected fractions in river sedi­
ments, swine feces lagoons, liquid manure, 
and farmed soil are markedly higher than 
those in aquatic compartments (Table 2). 
Concentrations of cipro floxacin, erythro­
mycin, and tetra cycline measured in river sedi­
ments are ≥ MIC50 values of ≤ 60%, 7.6%, 
and 6% of the bacterial genera, respectively 
(i.e., upper 95% CIs in Table 2). Estimated 
concentrations of these three anti biotics in the 
sediments of a swine feces lagoon are ≥ MIC50 
values of ≤ 92%, 21%, and 56% of the bacte­
rial genera. The extremely high concentration 
of tetra cycline in liquid manure reported by 
Hamscher (2006) is ≥ MIC50 of 100% of the 
bacterial genera. In contrast, the high con­
centration of tetra cycline measured in farmed 
soil is ≥ MIC50 for ≤ 30% of genera. We 
estimated that the tetra cycline concentration 
reported by Hamscher (2006) for farmed soil 
inhibits at least some isolates in up to 94% 
of the bacterial genera (i.e., NOEC species 
sensitivity distribution). Some environ ments, 
such as soil and sediments, are likely to con­
tain more bacterial genera of clinical relevance 
than others. Thus, for example, a potentially 
affected fraction of 30% for tetra cycline in 
farmed soil may inhibit more bacterial genera 
than a potentially affected fraction of 100% 
in liquid manure and therefore have larger 
public health implications.
For bacterial taxa represented in the 
MIC distribution of each anti biotic, we com­
pared MIC values ≥ COWT with measured 
environ mental concentrations (Figure 5).
Concentrations > COWT for a given bacterial 
taxa completely inhibit the wild­type popula­
tion, increasing the prevalence of resistance 
in the remaining active population to 100%. 
The measured environ mental concentration of 
cipro floxacin in swine feces lagoon sediment 
is > COWT for 14 bacterial taxa belonging to 
nine genera of predominantly enteric bacteria 
(Figure 5A). The concentration of tetra cycline 
measured in liquid manure is > COWT for all 
but one bacterial taxa, and the concentration 
measured in swine feces lagoon sediment is 
borderline with the COWT for Staphylococcus 
and Streptococcus (Figure 5C). Measured 
environ mental concentrations of erythro mycin 
are < COWT for all taxa (Figure 5B). 
Inhibitory effects at VICH phase I action 
limits. Potentially affected fractions at the 
VICH phase I aquatic action limit suggest 
that the action limit is protective of major 
inhibitory effects on bacteria by all three 
anti biotics (Figure 4), although a minority 
of sensitive individuals could be inhibited in 
up to 12% of genera (i.e., upper 95% CI in 
cipro floxacin NOEC species sensitivity distri­
bution) (Table 2). The 1­ppb VICH phase I 
aquatic action limit refers to an environ mental 
introduction concentration (i.e., concentration 
in an effluent); thus, exposure concentrations 
in receiving water bodies are further reduced 
by dilution.
Concentrations of cipro floxacin and 
erythro mycin at the VICH phase I soil action 
limit are estimated to be ≥ MIC50 values of 
≤ 76% and 25% of bacterial genera, respec­
tively (Figure 4, Table 2). Figure 4 shows that 
the VICH phase I soil action limit is below the 
erythro mycin and tetra cycline COWT for all 
species, indicating that at this concentration 
these anti biotics are not expected to inhibit 
100% of the wild­type population in any spe­
cies. Conversely, the cipro floxacin MIC distri­
butions (Figure 5A) show that the 100­ppb soil 
action limit is > COWT for five bacterial taxa 
and borderline with that for nine other taxa. 
It is also illustrative to consider these action 
limits in relation to the empirical MIC50 of indi­
vidual species. The MIC50 for cipro floxacin, for 
example, is 8 ppb in E. coli (n = 17,877), 8 ppb 
in Enterobacter cloacae (n = 2,354), 64 ppb 
in Acinetobacter lwoffi (n = 262), 125 ppb in 
Pseudomonas aerugi nosa (n = 27,387), and 
125 ppb in Campylobacter coli (n = 2,532). 
The MIC50 for erythro mycin is 32 ppb in 
Streptococcus pneumoniae (n = 40,452) and 
125 ppb in Staphylococcus aureus (n = 36,038). 
The MIC50 for tetra cycline is 32 ppb in 
Clostridium difficile (n = 832) and 125 ppb in 
Str. pneumoniae (n = 13,813). These MIC50 
are between 12.5 times lower to slightly higher 
than the 100­ppb soil action limit. Several spe­
cies also have NOECs that are orders of magni­
tude lower than the 100­ppb soil threshold.
Discussion
In this study we found that environ mental 
concentrations of anti biotics, as well as con­
centrations representing action limits used in 
the environ mental risk assessment of veteri­
nary medicines, may be high enough to inhibit 
growth in bacteria of clinical importance occur­
ing in different environ ments. By completely 
or partially inhibiting the growth of wild­type 
bacterial populations, anti biotics cause a selec­
tive pressure that will increase the prevalence of 
resistance. The potentially affected fractions for 
cipro floxacin, erythro mycin, and tetra cycline 
at measured environ mental concentrations of 
river sediments, swine feces lagoon sediments, 
liquid manure, and farmed soil suggest that 
Figure 5. MICs ≥ COWT for bacterial taxa in the MIC distributions of ciprofloxacin (A), erythro mycin (B), and tetracycline (C). Symbols represent the COWT for differ-
ent genera; dashed vertical lines extend up to the maximum MIC beyond the COWT; and horizontal lines represent anti biotic concentrations. The x-axis represents 
the number of bacterial taxa with a defined COWT for each antibiotic, and the y-axis indicates anti biotic concentrations. 
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these environ ments are likely to be hot spots 
for the selection of resistance. In this regard, 
the comparison of measured environ mental 
concentrations of cipro floxacin and tetra cycline 
and their respective COWT values in different 
bacteria is striking (Figure 5) because it shows 
that wild­type populations of certain species 
are completely inhibited at these concentra­
tions in vitro. In swine feces lagoons, liquid 
manure, and soil amended with manure, con­
centrations of certain anti biotics can build up 
to levels that may act to extend the anti biotic 
selective pressure that started for some bacteria 
within their treated hosts and exert a new selec­
tive pressure on other bacteria. Interestingly, 
in a study of soil from the 1970s to the pres­
ent, Knapp et al. (2010) found a significant 
increase in tetra cycline resistance genes that 
mimicked the use of tetra cyclines in agriculture 
in the Netherlands. Although studies have gen­
erally failed to find a significant effect of tetra­
cyclines on resistance levels in soil (e.g., Agersø 
et al. 2006), some evidence suggests that it 
could have contributed to the persistence and 
prevalence of resistance genes (Schmitt et al. 
2006). Our results indicate that tetra cycline 
concentrations in soil may build up to lev­
els high enough to exert a significant selective 
pressure on clinically relevant bacteria.
The extrapolation of MIC data to the field 
has inherent limitations that must be con­
sidered in the interpretation of our results. 
Physicochemical and biological conditions of 
MIC tests, for example, are not representa­
tive of those generally encountered by bacteria 
in the environ ment. MIC tests are also acute 
tests, whereas the exposure to anti biotics in the 
environ ment is mainly chronic and will exert a 
constant selective pressure over extended peri­
ods of time (Kümmerer 2009a; Sarmah et al. 
2006). Chronic exposure provides a longer 
temporal window for the selective enrich ment 
of resistance and will favor step wise transitions 
from low­level to high­level clinical resistance. 
In this study we did not formally address the 
bio availability of anti biotics in the environ­
ment. However, tetra cyclines and macrolides 
have been shown to retain their bioactivity 
and inhibit bacterial growth even when tightly 
adsorbed by clay particles (Chander et al. 
2005); there is also evidence to suggest that 
fluoro quinolones retain part of their activity 
when sorbed to solids (Córdova­Kreylos and 
Scow 2007). In the environ ment, bacteria are 
likely exposed to multiple anti biotics and other 
substances, such as metals and disinfectants, 
which will affect the selection of resistance. 
Synergistic and/or antagonistic inter actions 
between combinations of anti biotics, for exam­
ple, may significantly influence the evolution 
of resistance (Michel et al. 2008). Because 
many anti biotic resistance genes are associ­
ated with mobile genetic elements carrying 
multiple anti biotic resistance genes and genes 
conferring resistance to heavy metals and/or 
disinfectants (Chopra and Roberts 2001; Ciric 
et al. 2011), any of these factors may select for 
multi drug resistance. An example relevant to 
this study is the broad host range transposon 
Tn1545, which encodes resistance to tetra­
cycline, erythro mycin, and kanamycin (Clewell 
et al. 1995). In all, these factors emphasize the 
complexity of relating anti biotic pollution to 
the prevalence of anti biotic resistance in the 
environ ment, and inevitably introduce a degree 
of uncertainty in our results. Despite these 
limita tions, however, our results provide a 
means to grasp the potential effect of anti biotic 
pollution on the prevalence of resistance in 
clinically relevant bacteria in the environ ment 
by putting measured environ mental concentra­
tions in perspective with bacterial sensitivities.
The link between MIC50 and resistance 
is based on the assumption that anti biotic 
concentrations ≤ COWT may increase the 
prevalence of resistance to < 100% by inhibit­
ing a fraction of the wild­type population. 
Variation within the wild­type part of MIC 
distributions is normally in the order of 3–5 
log2 MIC steps (Schön et al. 2009). Although 
this variation may reflect inherent variation 
in anti biotic sensitivity and other biological 
features that influence the MIC, it may also 
reflect method variability. In environ mental 
compartments such as those discussed in this 
study, it is reasonable to expect some degree 
of inherent variation in the anti biotic sensitiv­
ity of wild­type popu la tions. Environments 
such as sewage, river sediments, and agricul­
tural soil act as transient or permanent sinks 
in which wild­type populations of the same 
species, from different sources, and with 
slightly differing sensitivities may physically 
converge. These environ ments are also likely 
to have micro gradients of physico chemical 
variables, such as pH and nutrients, that are 
known to affect the MIC of bacteria in vitro 
(Bonfiglio and Livermore 1991; Butler et al. 
2001). Collectively, these factors may provide 
enough variation in anti biotic sensitivity to 
enable the differential inhibition of wild­type 
populations under equal measured environ­
mental  concentrations of anti biotics.
The VICH phase I guidance document 
(VICH 2000) informs environ mental risk 
assessment of veterinary medicines and has 
been implemented in the regulatory scheme 
in the European Union, United States, Japan, 
and Australia (de Knecht et al. 2009). Under 
VICH phase I guidance, the environ mental 
risk assessment of a veterinary medicine—
except for parasiticides—is discontinued if 
the medicine’s introduction concentration 
into the aquatic environ ment is < 1 ppb (i.e., 
aquatic action limit). For terrestrial environ­
ments, environ mental risk assessment is dis­
continued if the predicted environ mental 
concentration in soil is < 100 ppb (i.e., soil 
action limit). Our results suggest that the 
VICH phase I soil action limit for veterinary 
medicines does not protect background anti­
biotic resistance levels. Certain anti biotics at 
concentrations < 100 ppb may inhibit a sig­
nificant fraction of clinically relevant bacte­
ria in the environ ment (Figure 4); the high 
potentially affected fractions for erythro­
mycin and cipro floxacin at the 100­ppb soil 
threshold are a clear example of this. In a cri­
tique of action limits, Montforts (2005) used 
MIC data from 13 soil micro organisms and 
22 antimicrobials to construct a substance–
species sensitivity distribution; on the basis 
of this distribution, he determined that the 
aquatic and soil action limits should be set at 
4 × 10–4 and 1 ppb, respectively, if they were 
to be protective for all compounds. Similarly, 
our results suggest that VICH phase I action 
limits leave an ample margin for anti biotics to 
exert a selective pressure on  bacteria of clinical 
importance in the environ ment.
Current knowledge on the presence and 
mechanisms of bacterial resistance of clini­
cal and environ mental origin clearly indicate 
that the resistome of pathogens is and will 
continue to be inevitably linked with the 
environ ment (Martinez 2008; Wright 2010). 
Moreover, as this study shows, the prevalence 
of resistance in bacteria of importance to pub­
lic health has the potential to be increased 
by anti biotic pollution in the environ ment. 
Therefore, to minimize the potential effect of 
anti biotic pollution on anti biotic resistance, 
resistance—or a proxy thereof—should be 
considered in environ mental risk assessment 
of human and veterinary anti biotics. 
MIC distributions are at the center of clini­
cal microbiology. In conjunction with drug 
pharmaco kinetics, MIC distributions are used 
to establish clini cal break points for the effective 
treatment of infectious diseases (MacGowan 
and Wise 2001; Turnidge and Paterson 2007). 
Similarly, we suggest that MIC distributions 
can be used to explicitly link environ mental 
concentrations of anti biotics with the preva­
lence of resistance, and can therefore provide 
a cogent framework to address the potential 
effects of anti biotics on anti biotic resistance in 
the initial phase of a risk assessment. Just as 
pharmaco kinetics provides information on the 
fate of anti biotics in the body, environ mental 
exposure assessment can be used to further 
refine the assessment of effects. If necessary, 
MIC distributions may be used to set break­
points to protect background resistance levels 
in the environ ment.
Conclusions
Anti biotics are present in different environ­
ments as a result of their use in human and 
veterinary medicine; concentrations currently 
found in different environments and con­
centrations representing action limits used in 
Tello et al.
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environ mental risk assessment may be high 
enough to exert a significant selective pressure 
on clinically relevant bacteria. The potentially 
affected fraction of bacterial genera at con­
centrations of anti biotics measured in river 
sediments, liquid manure, and farmed soil 
suggests that these environ ments are likely to 
be hot spots for the develop ment of resistance. 
Both explicit consideration of anti biotic resis­
tance in the environ mental risk assessment of 
anti biotics and efforts to reduce the input of 
anti biotics into the environ ment—by limiting 
use and/or improving the treatment of liquid 
and solid wastes—are crucial to maintaining 
background resistance levels. 
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